Recent publications on women's mental health - News Block

PMS AND PMDD

Exploring the diagnosis and treatment of premenstrual dysphoric disorder in the US healthcare system: a qualitative investigation.

Chan K, Rubtsova AA, Clark CJ.

BMC Women’s Health. 2023 May 17; 23(1):272.

The experiences of the participants demonstrated that much of the diagnostic and treatment processes fell on the patient, and that successful navigation within the health care system depended on high levels of self-advocacy.

Does treatment of symptom onset with sertraline improve functional decline in people with premenstrual dysphoric disorder?: a randomized controlled trial.

Yonkers KA, Altemus M, Gilstad-Hayden K, Kornstein SG, Gueorguieva R.

J Clin Psychopharmaco. 2023 Jul-Aug 01;43(4):320-325.

Only relationship functioning improved significantly with active treatment between the start and end of the second cycle.

INFERTILITY AND MENTAL HEALTH

There are no articles this week

PSYCHIATRIC ILLNESS DURING PREGNANCY

Sleep and its association with depressive and anxious symptoms during the last weeks of pregnancy: a population-based study.

Loret de Mola C, Carpena MX, Dias IM, Meucci R, Goicochea-Romero A, Cesar J.

Sleep Health. June 28, 2023: S2352-7218(23)00091-8.

Participants with an evening chronotype or shorter sleep duration were more likely to have depressive symptoms. Those who took longer to fall asleep or get out of bed were more likely to have both anxiety and depressive symptoms, but the association was stronger for depressive symptoms.

Prenatal depressive symptoms are associated with altered structural brain networks in infants and moderated by infant sleep.

Donnici C, Tomfohr-Madsen L, Long X, Manning KY, Giesbrecht G, Lebel C.

J Affects Disorder. 2023 June 28; 339: 118-126.

Prenatal depressive symptoms appear to affect early topological development in brain networks important for emotion regulation. In the limbic network, sleep duration moderated this relationship, suggesting that sleep may play a role in infant brain network development.

Consensus recommendations for the evaluation and treatment of perinatal obsessive-compulsive disorder (OCD): a Delphi study.

Mulcahy M, Long C, Morrow T, Galbally M, Rees C, Anderson R.

Arch Ment Health for women. June 2023; 26(3):389-399.

This study is the first to compile and outline a set of best clinical practice recommendations, developed using the consensus perspectives of both individuals with lived experience and professionals with relevant experience, to support people with perinatal OCD and their families.

MEDICATIONS AND PREGNANCY

Antidepressant treatment in pregnancy: a Danish registry linkage study in pregnant women with pre-existing obsessive-compulsive disorder.

Trinh NTH, Semark BD, Munk-Olsen T, Liu X, Thapa SB, Yilmaz Z, Petersen LV, Lupattelli A. Translation Psychiatry. 2023 June 23; 13(1):223.

Fetal exposure to SSRI antidepressants and infant sleep: findings from the MPEWS pregnancy cohort study.

Galbally M, Watson SJ, Nguyen T, Boyce P.

Child behavior development. June 28, 2023; 72:101849.

The antidepressants sertraline, escitalopram, and citalopram were not associated with increased wakefulness or infant wakefulness time. However, sertraline was associated with a longer time for a baby to fall asleep.

Determination of malformations in pregnancy registries: Lessons learned from the North American AED Pregnancy Registry.

Holmes LB, Quinn M, Conant S, Lyons A, Hauser WA, Yerby M, Hernandez-Diaz S.

Resolution of birth defects June 30, 2023.

POSTPARTUM PSYCHIATRIC ILLNESS

A systematic review of patient-reported outcome measures used in maternal postpartum anxiety.

O’Carroll J, Ando K, Yun R, Panelli D, Nicklin A, Kennedy N, Carvalho B, Blake L, Coker J, Kaysen D, Sultan P.

I am J Obstet Gynecol MFM. 2023 Jul 2:101076.

A total of 28 studies evaluating 13 instruments in 10,570 patients were included. Five instruments receiving a class A recommendation (recommended for use). The Postpartum Specific Anxiety Scale, the Postpartum Research Short Form Specific Anxiety Scale, the Covid Research Short Form Postpartum Specific Anxiety Scale, the Postpartum Specific Anxiety Scale – Persian, and the State-Trait Anxiety Inventory demonstrated adequate content validity and sufficient internal consistency.

5-year experience of a parent-baby day unit: impact on the development of the baby.

Moureau A, Cordemans L, Gregoire C, Benoit P, Delvenne V.

Frontal Psychiatry. 2023 June 15; 14:1121894.

The parent-baby day unit leads to positive results in clinical situations with anxious-depressive parents, relational withdrawal of babies, functional problems of babies but not when there is already a significant impact on the development of the baby.

MEDICATIONS AND BREASTFEEDING

There are no articles this week

PERINATAL USE OF SUBSTANCES

There are no articles this week

MATERNAL MENTAL HEALTH AND CHILD OUTCOMES

Association of severe maternal morbidity with impaired attachment and self-harm ideation: a multicenter prospective cohort study.

Terada S, Fujiwara T, Sugawara J, Maeda K, Satoh S, Mitsuda N.

J Affects Disorder. 2023 October 1; 338: 561-568.

Women with severe obstetric complications reported more problems with bonding, which was partially mediated by NICU admission. Psychotherapy to support parent-child relationships is necessary for women with MMS.

To examine the developmental timing implications of maternal trauma for prenatal and newborn outcomes.

Kaliush PR, Kerig PK, Raby KL, Maylott SE, Neff D, Speck B, Molina NC, Pappal AE, Parameswaran UD, Conradt E, Crowell SE.

Child behavior development. July 1, 2023; 72:101861.

Traumatic lifetime experiences were associated with multiple antenatal maternal health outcomes, including depression, anxiety, emotion dysregulation, and pregnancy complications. Pregnant women’s experiences with childhood trauma, but not adulthood or prenatal trauma, predicted higher neurobehavioral attention scores among newborns.